Free and Total Plasma Concentrations of Elvitegravir/cobicistat During Pregnancy and Postpartum: a Case Report

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 2017 May 18

PMID 28512794

Citations 9

Authors

Catia Marzolini

Laurent Decosterd

Ursula Winterfeld

Frederic Tissot

Katyuska Francini

Thierry Buclin

Francoise Livio

Affiliations

Soon will be listed here.

Citing Articles

Physiologic Changes During Pregnancy and Impact on Small-Molecule Drugs, Biologic (Monoclonal Antibody) Disposition, and Response.

Eke A, Gebreyohannes R, Fernandes M, Pillai V J Clin Pharmacol. 2023; 63 Suppl 1:S34-S50.

PMID: 37317492 PMC: 10365893. DOI: 10.1002/jcph.2227.

HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment.

Foster E, Gendelman H, Bade A Pharmaceuticals (Basel). 2022; 15(12).

PMID: 36558984 PMC: 9783753. DOI: 10.3390/ph15121533.

Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy.

Salama E, Eke A, Best B, Mirochnick M, Momper J J Clin Pharmacol. 2020; 60(12):1537-1550.

PMID: 32798276 PMC: 8227837. DOI: 10.1002/jcph.1714.

Drug-Drug Interactions with Antiretroviral Drugs in Pregnant Women Living with HIV: Are They Different from Non-Pregnant Individuals?.

Bukkems V, Colbers A, Marzolini C, Molto J, Burger D Clin Pharmacokinet. 2020; 59(10):1217-1236.

PMID: 32696442 PMC: 7550380. DOI: 10.1007/s40262-020-00914-x.

Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV.

Momper J, Best B, Wang J, Capparelli E, Stek A, Barr E AIDS. 2018; 32(17):2507-2516.

PMID: 30134297 PMC: 6209536. DOI: 10.1097/QAD.0000000000001992.

References

Schalkwijk S, Colbers A, Konopnicki D, Greupink R, Russel F, Burger D . First reported use of elvitegravir and cobicistat during pregnancy. AIDS. 2016; 30(5):807-8. DOI: 10.1097/QAD.0000000000000976. View

Aouri M, Calmy A, Hirschel B, Telenti A, Buclin T, Cavassini M . A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients. J Mass Spectrom. 2013; 48(5):616-25. DOI: 10.1002/jms.3200. View

Marzolini C, Decosterd L, Winterfeld U, Tissot F, Francini K, Buclin T . Free and total plasma concentrations of elvitegravir/cobicistat during pregnancy and postpartum: a case report. Br J Clin Pharmacol. 2017; 83(12):2835-2838. PMC: 5698588. DOI: 10.1111/bcp.13310. View

Barcelo C, Gaspar F, Aouri M, Panchaud A, Rotger M, Guidi M . Population pharmacokinetic analysis of elvitegravir and cobicistat in HIV-1-infected individuals. J Antimicrob Chemother. 2016; 71(7):1933-42. DOI: 10.1093/jac/dkw050. View

Podany A, Scarsi K, Fletcher C . Comparative Clinical Pharmacokinetics and Pharmacodynamics of HIV-1 Integrase Strand Transfer Inhibitors. Clin Pharmacokinet. 2016; 56(1):25-40. PMC: 5164870. DOI: 10.1007/s40262-016-0424-1. View

Hong H, Branham W, Ng H, Moland C, Dial S, Fang H . Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein. Toxicol Sci. 2014; 143(2):333-48. DOI: 10.1093/toxsci/kfu231. View

Aweeka F, Hu C, Huang L, Best B, Stek A, Lizak P . Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics. HIV Med. 2014; 16(3):176-83. PMC: 4320673. DOI: 10.1111/hiv.12195. View

Pennell K, Woodin M, Pennell P . Quantification of neurosteroids during pregnancy using selective ion monitoring mass spectrometry. Steroids. 2014; 95:24-31. PMC: 4323841. DOI: 10.1016/j.steroids.2014.12.007. View

Southan C, Sharman J, Benson H, Faccenda E, Pawson A, Alexander S . The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucleic Acids Res. 2015; 44(D1):D1054-68. PMC: 4702778. DOI: 10.1093/nar/gkv1037. View

10.

Fayet A, Beguin A, Martinez de Tejada B, Colombo S, Cavassini M, Gerber S . Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction. Ther Drug Monit. 2008; 30(4):511-22. DOI: 10.1097/FTD.0b013e3181817318. View

11.

Jeong H, Choi S, Song J, Chen H, Fischer J . Regulation of UDP-glucuronosyltransferase (UGT) 1A1 by progesterone and its impact on labetalol elimination. Xenobiotica. 2007; 38(1):62-75. PMC: 3691104. DOI: 10.1080/00498250701744633. View